Literature DB >> 1942285

Vertebral mineral content in diet-dependent and diet-independent hypercalciuria.

L Borghi1, T Meschi, A Guerra, L Maninetti, M Pedrazzoni, A Marcato, P Vescovi, A Novarini.   

Abstract

The vertebral mineral content was measured using dual photon absorptiometry in 41 calcium stone patients with idiopathic hypercalciuria. These patients had been previously divided into 2 groups (diet-dependent and diet-independent hypercalciuria) during a low sodium and low calcium diet. In some of the patients (11 with diet-dependent and 11 with diet-independent hypercalciuria) the vertebral mineral content was evaluated in relation to serum ionized calcium, intact parathyroid hormone, alkaline phosphatase and osteocalcin determined after a low sodium and low calcium diet. The vertebral mineral content, expressed as Z-VMD, was normal in diet-dependent and lower in diet-independent hypercalciuric stone patients (-0.30 +/- 1.19 versus -0.26 +/- 1.18, p less than 0.02). In 7 of 21 patients (33.3%) the vertebral mineral content was less than 2 standard deviations of the normal value, indicating a true involvement in bone metabolism. Serum intact parathyroid hormone and osteocalcin levels were not different from the controls in both groups, while alkaline phosphatase activity and ionized calcium were higher in diet-independent hypercalciuric patients. Serum ionized calcium was negatively correlated with bone vertebral density. The results suggest that an increased bone turnover may be a primary event in causing hypercalciuria in calcium stone patients unable to decrease urinary calcium to less than the calcium intake.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942285     DOI: 10.1016/s0022-5347(17)38083-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

2.  Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug.

Authors:  Gerolamo Bianchi; Andrea Giusti; Giulio Pioli; Antonella Barone; Ernesto Palummeri; Giuseppe Girasole
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

3.  Idiopathic hypercalciuria: O2(-)NO relationship and altered bone metabolism.

Authors:  L Calò; S Giannini; P Bonvicini; M Nobile; S Cantaro; M Plebani; A Semplicini; A D'Angelo; G Crepaldi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

Review 4.  Nephrolithiasis-associated bone disease: pathogenesis and treatment options.

Authors:  Khashayar Sakhaee; Naim M Maalouf; Rajiv Kumar; Andreas Pasch; Orson W Moe
Journal:  Kidney Int       Date:  2010-12-01       Impact factor: 10.612

5.  Long-term potassium citrate therapy and bone mineral density in idiopathic calcium stone formers.

Authors:  F Vescini; A Buffa; G La Manna; A Ciavatti; E Rizzoli; A Bottura; S Stefoni; R Caudarella
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

6.  Bone disease in primary hypercalciuria.

Authors:  Stefania Sella; Catia Cattelan; Giuseppe Realdi; Sandro Giannini
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 7.  Bone mineral content in calcium renal stone formers.

Authors:  A Trinchieri
Journal:  Urol Res       Date:  2005-08-03

8.  Relationship between renal stone formation, mitral annular calcification and bone resorption markers.

Authors:  Ahmet Celik; Vedat Davutoglu; Kemal Sarica; Sakip Erturhan; Orhan Ozer; Ibrahim Sari; Mustafa Yilmaz; Yasemin Baltaci; Murat Akcay; Behcet Al; Murat Yuce; Necat Yilmaz
Journal:  Ann Saudi Med       Date:  2010 Jul-Aug       Impact factor: 1.526

9.  Low bone density in children with hypercalciuria and/or nephrolithiasis.

Authors:  Andrew L Schwaderer; Robert Cronin; John D Mahan; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

Review 10.  Pathophysiology of hypercalciuria in children.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2007-04-27       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.